Search for: "ACTAVIS"
Results 641 - 660
of 1,006
Sort by Relevance
|
Sort by Date
11 Oct 2013, 9:34 pm
The American Bar Association (ABA) Section of Intellectual Property Law, Young Lawyers Division, and Center for Professional Development will be offering a live webinar on "Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act Post-Actavis" on October 22, 2013 from 2:00 to 3:30 pm (Eastern). [read post]
30 Sep 2013, 4:50 am
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on AZILECT® ----- Patent Awarded to New… [read post]
22 Sep 2013, 6:58 am
Actavis The following articles are pre-publication versions of articles that will appear in MJLST Volume 15, Issue 1. [read post]
23 Aug 2013, 3:27 am
Actavis, the Court confronted the law governing a controversial pharmaceutical marketing practice known as reverse payment agreements, or pay for delay.1 This practice occurs when a generic drug company identifies a vulnerable patent held by a brand-name drug manufacturer and seeks approval from the Food and Drug Administration (FDA) for a generic version before the patent expires, provoking a lawsuit for infringement. [read post]
22 Aug 2013, 9:59 pm
Actavis), the Federal Trade Commission has filed an amicus curiae brief with the District Court of New Jersey in In re Effexot XR Antitrust Litigation. [read post]
22 Aug 2013, 1:34 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals, which is now known as Actavis, Inc. [read post]
20 Aug 2013, 7:57 am
Actavis South Atlantic LLC, et al., C.A. [read post]
16 Aug 2013, 12:39 pm
Hovenkamp, Anticompetitive Patent Settlements and the Supreme Court's Actavis Decision, 15 Minn. [read post]
16 Aug 2013, 9:57 am
Actavis to a patent settlement containing a “no-authorized-generic” commitment. [read post]
16 Aug 2013, 9:57 am
Actavis to a patent settlement containing a “no-authorized-generic” commitment. [read post]
29 Jul 2013, 8:45 am
Actavis the Supreme Court held that settlement of a patent infringement suit in which the patentee of a... [read post]
29 Jul 2013, 5:00 am
Actavis,... [read post]
14 Jul 2013, 9:01 pm
Actavis: Practical Implications of the Landmark Supreme Court Decision (Law Seminars International) - 3:00 to 4:00 pm (Eastern) July 17, 2013 - European biotech patent law update (D Young & Co) - 4:00 am, 7:00 am, 12:00 pm (EDT) July 17, 2013 - The Myriad Decision: Practical Implications for Biotechnology Companies Protecting IP Assets (Law Seminars International) - 3:00 to... [read post]
11 Jul 2013, 7:37 am
Actavis. [read post]
9 Jul 2013, 7:38 am
Here are just a few of the larger healthcare M&A deals in 2013: Valeant Pharmaceuticals to acquire Bausch + Lomb Holdings for $8.7 billion Actavis to acquire Warner Chilcott for approximately $8.5 billion McKesson acquires PSS World Medical for approximately $2.1 billion Catholic Health Initiatives acquires St. [read post]
5 Jul 2013, 8:42 pm
Actavis: Practical Implications of the Landmark Supreme Court Decision" on July 16, 2013 from 3:00 to 4:00 pm (Eastern). [read post]
3 Jul 2013, 5:48 am
Actavis Mid Atlantic, concerning the breadth of an advance waiver between a sophisticated client and law firm, should be reviewed very carefully by in-house and outside counsel. [read post]
1 Jul 2013, 9:59 pm
Actavis, Inc. and Mutual Pharmaceutical Co. v. [read post]
1 Jul 2013, 6:00 am
Actavis. [read post]
30 Jun 2013, 10:03 pm
Actavis, Inc., No. 12-416 (U.S. [read post]
